Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19
Helena Janols(Evidence (Italy)), Sarah Nikiforow(Otsuka (Japan)), Michael K. Mansour(Harvard University), Ruta Shah(Evidence (Italy)), José A. Pérez‐Molina(Instituto de Salud Carlos III), Vicente Estrada(Evidence (Italy)), Maria Ema Molas(Evidence (Italy)), Jesús Fortün(Evidence (Italy)), Félix Gutiérrez(Universitat de Miguel Hernández d'Elx), Harry Shrager(Evidence (Italy)), Michael Pincus(Evidence (Italy)), Ferràn Torres(Evidence (Italy)), Andrea S. Foulkes(Harvard University), Jorge Fleisher(Evidence (Italy)), Jorge Malouf(Evidence (Italy)), Juan Pablo Horcajada(Evidence (Italy)), Ulla Hohenthal(Evidence (Italy)), Naomi J. Patel(Evidence (Italy)), Manish Sagar(Evidence (Italy)), Harri Marttila(Evidence (Italy)), Víctor Asensi(Baylor College of Medicine), Brian C. Healy(Evidence (Italy)), Noemí Corbacho(Evidence (Italy)), Paul Skorup(Evidence (Italy)), Natividad Benito(Evidence (Italy)), Ann E. Woolley(Evidence (Italy)), Ana Maria Bensaci(Evidence (Italy)), Ana D. Fernandes(Universidade do Estado do Rio de Janeiro), Matthew J. Frigault(Harvard University), Jan Vesterbacka(Evidence (Italy)), Tytti Vuorinen(Evidence (Italy)), Matthew Axelrod(Evidence (Italy)), Virginia Pomar(Evidence (Italy)), Jon Lampa(Evidence (Italy)), Johan Rasmuson(Evidence (Italy)), Luisa María Villar(Evidence (Italy)), Marika Nordberg(Evidence (Italy)), David S. Huckins(Evidence (Italy)), Isabel Mur(Evidence (Italy)), Liam Harvey(Evidence (Italy)), Piotr Nowak(Evidence (Italy)), Jessica Muñoz(Evidence (Italy)), Mika Valtonen(Evidence (Italy)), L F Pascual Millán(Evidence (Italy)), María del Mar Gutiérrez(Evidence (Italy)), Gràcia Mateo(Evidence (Italy)), Silvia Herrera(Evidence (Italy)), Nina Lin(Evidence (Italy))
Cited by 723
Related Papers
Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis
|Science|2022|2k
Detection of SARS-CoV-2 with SHERLOCK One-Pot Testing
|New England Journal of Medicine|2020|801
Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|560
NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020
|Journal of the National Comprehensive Cancer Network|2020|484
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma
|Journal of Clinical Oncology|2017|468